{
  "4319679": "===============================================\nBRONCHOSCOPY PROCEDURE REPORT\n===============================================\nPatient: [REDACTED]\nMRN: [REDACTED]\nDOB: [REDACTED]\nDate: [REDACTED]\nPhysician: Jennifer Walsh, MD\n===============================================\n\n[INDICATION]\nPrimary: Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy\nCategory: Lung Cancer Staging\nTarget: 23.2mm Ground-glass lesion, LLL lateral basal (B9)\nBronchus Sign: Positive\nPET SUV: 16.0\n\n[ANESTHESIA]\nType: General endotracheal anesthesia\nASA Class: 3\nAirway: 8.0mm ETT\nDuration: 105 minutes\n\n[DESCRIPTION]\nProcedure 1: Linear EBUS-TBNA\n- Scope: Olympus BF-UC180F\n- Needle: 19G FNB/ProCore\n- Stations sampled: 11R, 2L, 4L\n- Number of stations: 3 (â‰¥3)\n- ROSE available: Yes\n- ROSE result: Suspicious for malignancy\n\nProcedure 2: Robotic Bronchoscopy\n- Platform: Galaxy (Noah Medical)\n- Registration: CT-to-body, error 2.8mm\n- Target: LLL lateral basal (B9)\n\nProcedure 3: Radial EBUS\n- View: Eccentric\n- Confirmation: Radial EBUS\n\nProcedure 4: Transbronchial Biopsy\n- Forceps biopsies: 7\n- TBNA passes: 2\n- Brushings: 2\n- ROSE result: Suspicious for malignancy\n\nSpecimens: Cytology, cell block, surgical pathology, BAL cultures\nComplications: None\nEBL: <10mL\n\n[PLAN]\n1. Post-procedure monitoring x2 hours\n2. Chest X-ray - completed, no pneumothorax\n3. Discharge to home if stable\n4. Follow-up: 1-2 weeks for pathology\n5. Tumor board review pending final results\n6. Molecular testing if malignancy confirmed\n\n===============================================\nElectronically signed: Jennifer Walsh, MD\nDate: [REDACTED]\n==============================================="
}
